tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AbbVie Advances with Emraclidine Study in Elderly: A Potential Game Changer?
PremiumCompany AnnouncementsAbbVie Advances with Emraclidine Study in Elderly: A Potential Game Changer?
2d ago
AbbVie’s New Study on ELAPR002f Gel: A Potential Game-Changer for Acne Scars
Premium
Company Announcements
AbbVie’s New Study on ELAPR002f Gel: A Potential Game-Changer for Acne Scars
2d ago
AbbVie’s New Phase 2 Study Targets MET Amplification in Solid Tumors
Premium
Company Announcements
AbbVie’s New Phase 2 Study Targets MET Amplification in Solid Tumors
2d ago
AbbVie Withdraws Study on Hair Loss in Oriahnn Users: Market Implications
PremiumCompany AnnouncementsAbbVie Withdraws Study on Hair Loss in Oriahnn Users: Market Implications
2d ago
AbbVie’s AML Study Termination: Implications for Investors
Premium
Company Announcements
AbbVie’s AML Study Termination: Implications for Investors
2d ago
AbbVie’s Elagolix Pregnancy Study Terminated: Market Implications
Premium
Company Announcements
AbbVie’s Elagolix Pregnancy Study Terminated: Market Implications
2d ago
AbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges
PremiumRatingsAbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges
5d ago
AbbVie’s Atogepant Study: A Step Forward in Migraine Prevention
Premium
Company Announcements
AbbVie’s Atogepant Study: A Step Forward in Migraine Prevention
8d ago
AbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study
9d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100